On-treatment platelet reactivity in peripheral and coronary blood in patients undergoing primary PCI for ST-segment elevation myocardial infarction (STEMI)

References

• Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and re-thrombosis on evolving thrombi. Circulation. 1992;86(6 Suppl):III74–85.
   Web of Science ®Google Scholar
• Van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36–44.
   PubMed Web of Science ®Google Scholar
• Grech ED, Ramsdale DR. Acute coronary syndrome: ST segment elevation myocardial infarction. Bmj. 2003;326:1379–1381.
   PubMedGoogle Scholar
• Schaar JA, Muller JE, Falk E, et al. Terminology for high-risk and vulnerable coronary artery plaques. Report of a meeting on the vulnerable plaque, June 17 and 18, 2003, Santorini, Greece. Eur Heart J. 2004;25:1077–1082.
   PubMed Web of Science ®Google Scholar
• Davì G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–2494.
   PubMed Web of Science ®Google Scholar
• Steinhubl S. How important is preventing platelet activation in the setting of percutaneous coronary intervention? J Invasive Cardiol. 2004;16(Suppl G):3–7.
   PubMedGoogle Scholar
• Fintel DJ. Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options. Vasc Health Risk Manag. 2012;8:77–89.
   PubMedGoogle Scholar
• Marcucci R, Cenci C, Cioni G, et al. Antiplatelets in acute coronary syndrome: personal perspectives. Expert Rev Cardiovasc Ther. 2012;10:1487–1496.
   PubMedGoogle Scholar
• Mayer K, Bernlochner I, Braun S, et al. Aspirin treatment and outcomes after percutaneous coronary intervention: results of the ISAR-ASPI registry. J Am Coll Cardiol. 2014;64:863–871.
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Mahla E, Antonino MJ, et al. Response variability and the role of platelet function testing. J Invasive Cardiol. 2009;21:172–178.
   PubMed Web of Science ®Google Scholar
• Gross L, Araldi D, Sibbing D. Platelet function testing in patients on antiplatelet medications. Semin Thromb Hemost. 2016;42:306–320.
   PubMed Web of Science ®Google Scholar
• Grove EL, Hvas AM, Kristensen SD. Aspirin resistance: myth or major problem? Scand J Clin Lab Investig. 2008;68:257–259.
   PubMed Web of Science ®Google Scholar
• Dieter RS, Lopez JJ, Nanjundappa A. Platelet resistance – much known and much more unknown. J Invasive Cardiol. 2011;23:14.
   PubMed Web of Science ®Google Scholar
• Parodi G, Marcucci R, Valenti R, et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. Jama. 2011;306:1215–1223.
   PubMed Web of Science ®Google Scholar
• Gori AM, Grifoni E, Valenti R, et al. High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI. Eur J Intern Med. 2016;30:49–54.
   PubMed Web of Science ®Google Scholar
• Thomas MR, Storey RF. Clinical significance of residual platelet reactivity in patients treated with platelet P2Y12 inhibitors. Vascul Pharmacol. 2016;84:25–27.
   PubMed Web of Science ®Google Scholar
• Feher G, Feher A, Pusch G, et al. Clinical importance of aspirin and clopidogrel resistance. World J Cardiol. 2010;2:171–186.
   PubMedGoogle Scholar
• Le Quellec S, Bordet JC, Negrier C, et al. Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literature. Thromb Haemost. 2016;116:638–650.
   PubMed Web of Science ®Google Scholar
• Hu YF, Lu TM, Wu CH, et al. Differences in high on-treatment platelet reactivity between intra-coronary and peripheral blood after dual anti-platelet agents in patients with coronary artery disease. Thromb Haemost. 2013;110:124–130.
   PubMed Web of Science ®Google Scholar
• Gary T, Prüller F, Raggam R, et al. High residual collagen-induced platelet reactivity predicts development of restenosis in the superficial femoral artery after percutaneous transluminal angioplasty in claudicant patients. Cardiovasc Intervent Radiol. 2016;39:190–194.
   PubMed Web of Science ®Google Scholar
• Kafian S, Mobarrez F, Kalani M, et al. Comparison of venous and arterial blood sampling for the assessment of platelet aggregation with whole blood impedance aggregometry. Scand J Clin Lab Investig. 2011;71:637–640.
   PubMed Web of Science ®Google Scholar
• Oswald E, Finsterwalder T, Innerhofer N, et al. Comparison of arterial versus venous parameters of rotational thromboelastometry and multiple platelet function analyzer: results of a pilot study. Scand J Clin Lab Investig. 2013;73:538–545.
   PubMed Web of Science ®Google Scholar
• Shah B, Sedlis SP, Mai X, et al. Comparison of platelet activity measurements by use of arterial and venous blood sampling. J Thromb Haemost. 2013;11:1922–1924.
   PubMed Web of Science ®Google Scholar
• Yong AS, Pennings GJ, Chang M, et al. Intracoronary shear-related up-regulation of platelet P-selectin and platelet-monocyte aggregation despite the use of aspirin and clopidogrel. Blood. 2011;117:11–20.
   PubMed Web of Science ®Google Scholar
• Martínez GJ, Barraclough JY, Nakhla S, et al. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients. Biosci Rep. 2017;37:BSR20160430.
   PubMed Web of Science ®Google Scholar
• Campello E, Spiezia L, Zabeo E, et al. Hypercoagulability detected by whole blood thromboelastometry (ROTEM®) and impedance aggregometry (MULTIPLATE®) in obese patients. Thromb Res. 2015;135:548–553.
   PubMed Web of Science ®Google Scholar
• Tóth O, Calatzis A, Penz S, et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006;96:781–788.
   PubMed Web of Science ®Google Scholar
• Weitz JI. Insights into the role of thrombin in the pathogenesis of recurrent ischaemia after acute coronary syndrome. Thromb Haemost. 2014;112:924–931.
   PubMed Web of Science ®Google Scholar
• Kim YG, Suh JW, Park JJ, et al. Different influences of hematocrit on the results of two point-of-care platelet function tests, the VerifyNow assay and multiple electrode platelet aggregometry. PLoS One. 2014;9:e114053.
   PubMed Web of Science ®Google Scholar
• Verdoia M, Pergolini P, Rolla R, et al. Gender differences in platelet reactivity in patients receiving dual antiplatelet therapy. Cardiovasc Drugs Ther. 2016;30:143–150.
   PubMed Web of Science ®Google Scholar
• Rubak P, Villadsen K, Hvas AM. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res. 2012;130:420–423.
   PubMed Web of Science ®Google Scholar
• Feher G, Koltai K, Alkonyi B, et al. Clopidogrel resistance: role of body mass and concomitant medications. Int J Cardiol. 2007;120:188–192.
   PubMed Web of Science ®Google Scholar
• Danielak D, Komosa A, Tomczak A, et al. Determinants of high on-treatment platelet reactivity and agreement between VerifyNow and Multiplate assays. Scand J Clin Lab Investig. 2017;77:190–198.
   PubMed Web of Science ®Google Scholar
• Feher G, Koltai K, Papp E, et al. Aspirin resistance: possible roles of cardiovascular risk factors, previous disease history, concomitant medications and haemorrheological variables. Drugs Aging. 2006;23:559–567.
   PubMed Web of Science ®Google Scholar
• Mortensen SB, Larsen SB, Grove EL, et al. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res. 2010;126:318–322.
   Web of Science ®Google Scholar
• Snoep JD, Hovens MM, Eikenboom JC, et al. Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis. Am Heart J. 2007;154:221–231.
   PubMed Web of Science ®Google Scholar
• Olivier CB, Diehl P, Schnabel K, et al. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry. Thromb Haemost. 2014;111:266–272.
   PubMed Web of Science ®Google Scholar
• Siller-Matula JM, Hintermeier A, Kastner J, et al. Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor. Vascul Pharmacol. 2016;79:6–10.
   PubMed Web of Science ®Google Scholar
• Leunissen TC, Janssen PW, Ten Berg JM, et al. The use of platelet reactivity testing in patients on antiplatelet therapy for prediction of bleeding events after cardiac surgery. Vascul Pharmacol. 2016;77:19–27.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med. 2010;48:579–598.
   PubMed Web of Science ®Google Scholar
• Lancé MD, Henskens YM, Nelemans P, et al. Do blood collection methods influence whole-blood platelet function analysis?. Platelets. 2013;24:275–281.
   PubMed Web of Science ®Google Scholar
• Sweeney JD, Hoernig LA, Michnik A, et al. Whole blood aggregometry. Influence of sample collection and delay in study performance on test results. Am J Clin Pathol. 1989;92:676–679.
   PubMed Web of Science ®Google Scholar
• Müller MR, Salat A, Pulaki S, et al. Influence of hematocrit and platelet count on impedance and reactivity of whole blood for electrical aggregometry. J Pharmacol Toxicol Methods. 1995;34:17–22.
   PubMed Web of Science ®Google Scholar
• Scharbert G, Kalb M, Marschalek C, et al. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg. 2006;102:1280–1284.
   PubMed Web of Science ®Google Scholar
• Paniccia R, Priora R, Liotta AA, et al. Platelet function tests: a comparative review. Vasc Health Risk Manag. 2015;11:133–148.
   PubMed Web of Science ®Google Scholar
• Meen O, Brosstad F, Liestøl K, et al. Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction. Scand J Clin Lab Investig. 2012;72:318–325.
   PubMed Web of Science ®Google Scholar
• Kaiser AF, Neubauer H, Franken CC, et al. Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions. Platelets. 2012;23:359–367.
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Yu LH, Kim MH. Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin. Platelets. 2013;24:339–347.
   PubMed Web of Science ®Google Scholar
• Yong AS, Pennings GJ, Chung T, et al. Intravascular blood sampling using the Export catheter does not induce artifactual platelet activation. J Invasive Cardiol. 2009;4:159–161.
   Google Scholar